TELCON RF PHARMACEUTICAL. Inc. (KOSDAQ:200230)
South Korea · Delayed Price · Currency is KRW 1,139.00
-74.00 (-6.10%)
Oct 31, 2025, 3:30 PM KST
TELCON RF PHARMACEUTICAL. Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Operating Revenue | 41,016 | 37,865 | 36,307 | 27,830 | 37,841 | 33,141 | Upgrade |
Other Revenue | 0 | - | -0 | - | -0 | - | Upgrade |
| 41,016 | 37,865 | 36,307 | 27,830 | 37,841 | 33,141 | Upgrade | |
Revenue Growth (YoY) | 6.16% | 4.29% | 30.46% | -26.46% | 14.18% | -41.44% | Upgrade |
Cost of Revenue | 30,907 | 27,628 | 26,800 | 22,267 | 28,780 | 25,905 | Upgrade |
Gross Profit | 10,109 | 10,237 | 9,507 | 5,563 | 9,061 | 7,236 | Upgrade |
Selling, General & Admin | 6,203 | 6,252 | 4,484 | 4,554 | 6,949 | 7,391 | Upgrade |
Research & Development | 731.84 | 722.94 | 733.17 | 1,208 | 1,635 | 1,817 | Upgrade |
Amortization of Goodwill & Intangibles | 2,523 | 2,548 | 2,565 | 2,582 | 2,597 | 2,595 | Upgrade |
Other Operating Expenses | 228.39 | 112.54 | 59.76 | 68.03 | 168.3 | 53.62 | Upgrade |
Operating Expenses | 10,110 | 10,307 | 8,542 | 9,626 | 13,624 | 9,326 | Upgrade |
Operating Income | -1.75 | -70.55 | 965.32 | -4,063 | -4,563 | -2,090 | Upgrade |
Interest Expense | -5,520 | -3,760 | -603.58 | -1,063 | -7,702 | -2,849 | Upgrade |
Interest & Investment Income | 481.57 | 324.97 | 205.05 | 61.42 | 45.48 | 57.21 | Upgrade |
Earnings From Equity Investments | -18,358 | -24,684 | 469.53 | -17,868 | -13,196 | -39,204 | Upgrade |
Currency Exchange Gain (Loss) | -49.75 | 602.71 | 119.08 | 318.02 | 831.71 | 178.36 | Upgrade |
Other Non Operating Income (Expenses) | -6,133 | 1,119 | -837.92 | -1,981 | 77.32 | -135.85 | Upgrade |
EBT Excluding Unusual Items | -29,581 | -26,468 | 317.48 | -24,595 | -24,507 | -44,042 | Upgrade |
Impairment of Goodwill | - | - | - | - | - | -4,179 | Upgrade |
Gain (Loss) on Sale of Investments | 5,532 | 1,275 | 13,466 | -13,146 | 4,626 | 9,010 | Upgrade |
Gain (Loss) on Sale of Assets | -0.05 | 17.27 | -14.8 | 34.38 | 10.31 | -179.33 | Upgrade |
Asset Writedown | -1,125 | -1,097 | -64.8 | -4,411 | -3,005 | -51.13 | Upgrade |
Other Unusual Items | -434.02 | -227.31 | 244.63 | - | - | -2,209 | Upgrade |
Pretax Income | -25,608 | -26,500 | 13,949 | -42,117 | -22,875 | -41,652 | Upgrade |
Income Tax Expense | - | - | - | - | - | 18.95 | Upgrade |
Earnings From Continuing Operations | -25,608 | -26,500 | 13,949 | -42,117 | -22,875 | -41,671 | Upgrade |
Earnings From Discontinued Operations | - | - | - | - | -331.42 | -355.73 | Upgrade |
Net Income to Company | -25,608 | -26,500 | 13,949 | -42,117 | -23,207 | -42,027 | Upgrade |
Minority Interest in Earnings | 6.07 | 180.11 | -42.34 | 32.81 | 108.8 | 1,134 | Upgrade |
Net Income | -25,602 | -26,320 | 13,906 | -42,084 | -23,098 | -40,893 | Upgrade |
Net Income to Common | -25,602 | -26,320 | 13,906 | -42,084 | -23,098 | -40,893 | Upgrade |
Shares Outstanding (Basic) | 36 | 35 | 34 | 32 | 26 | 26 | Upgrade |
Shares Outstanding (Diluted) | 36 | 35 | 45 | 41 | 26 | 26 | Upgrade |
Shares Change (YoY) | 5.06% | -20.89% | 8.89% | 56.33% | 2.65% | 3.29% | Upgrade |
EPS (Basic) | -709.92 | -741.54 | 414.65 | -1322.39 | -876.43 | -1592.68 | Upgrade |
EPS (Diluted) | -710.15 | -741.67 | 341.71 | -1322.39 | -876.43 | -1593.85 | Upgrade |
Free Cash Flow | -3,930 | -3,749 | -4,954 | -2,912 | -2,613 | 1,671 | Upgrade |
Free Cash Flow Per Share | -108.98 | -105.63 | -110.43 | -70.69 | -99.13 | 65.08 | Upgrade |
Gross Margin | 24.64% | 27.03% | 26.19% | 19.99% | 23.95% | 21.83% | Upgrade |
Operating Margin | -0.00% | -0.19% | 2.66% | -14.60% | -12.06% | -6.31% | Upgrade |
Profit Margin | -62.42% | -69.51% | 38.30% | -151.22% | -61.04% | -123.39% | Upgrade |
Free Cash Flow Margin | -9.58% | -9.90% | -13.64% | -10.46% | -6.90% | 5.04% | Upgrade |
EBITDA | 4,561 | 4,436 | 5,210 | 218.47 | -363.07 | 2,307 | Upgrade |
EBITDA Margin | 11.12% | 11.72% | 14.35% | 0.78% | -0.96% | 6.96% | Upgrade |
D&A For EBITDA | 4,562 | 4,507 | 4,244 | 4,281 | 4,200 | 4,397 | Upgrade |
EBIT | -1.75 | -70.55 | 965.32 | -4,063 | -4,563 | -2,090 | Upgrade |
EBIT Margin | -0.00% | -0.19% | 2.66% | -14.60% | -12.06% | -6.31% | Upgrade |
Advertising Expenses | - | 35.06 | 10.77 | 45.18 | 3.36 | 18.62 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.